Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Oct 1;178(4):1189–1197. doi: 10.1084/jem.178.4.1189

Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain

PMCID: PMC2191195  PMID: 8376928

Abstract

Males from the BXSB murine strain (H-2b) spontaneously develop an autoimmune syndrome with features of systemic lupus erythematosus (SLE), which results in part from the action of a mutant gene (Yaa) located on the Y chromosome. Like other H-2b mice, the BXSB strain does not express the class II major histocompatibility complex antigen, I-E. Here we report that the expression of I-E (E alpha dE beta b) in BXSB males bearing an E alpha d transgene prevents hypergammaglobulinemia, autoantibody production, and subsequent autoimmune glomerulonephritis. These transgenic mice bear on the majority of their B cells not only I- E molecules, but also an I-E alpha chain-derived peptide presented by a higher number of I-Ab molecules, as recognized by the Y-Ae monoclonal antibody. The I-E+ B cells appear less activated in vivo than the I-E- B cells, a minor population. This limited activation of the I-E+ B cells does not reflect a functional deficiency of this cell population, since it can be stimulated to IgM production in vitro by lipopolysaccharides at an even higher level than the I-E- B cell population. The development of the autoimmune syndrome in the transgenic and nontransgenic bone marrow chimeric mice argues against the possibility that the induction of regulatory T cells or clonal deletion of potential autoreactive T cells as a result of I-E expression is a mechanism of the protection conferred by the E alpha d transgene. We propose a novel mechanism by which the E alpha d transgene protects BXSB mice against SLE: overexpression of I-E alpha chains results in the generation of excessive amounts of a peptide displaying a high affinity to the I-Ab molecule, thereby competing with pathogenic autoantigen-derived peptides for presentation by B lymphocytes and preventing their excessive stimulation.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., McDevitt H. O. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2435–2439. doi: 10.1073/pnas.84.8.2435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bazin H., Cormont F., De Clercq L. Purification of rat monoclonal antibodies. Methods Enzymol. 1986;121:638–652. doi: 10.1016/0076-6879(86)21063-0. [DOI] [PubMed] [Google Scholar]
  4. Burkly L. C., Lo D., Cowing C., Palmiter R. D., Brinster R. L., Flavell R. A. Selective expression of class II E alpha d gene in transgenic mice. J Immunol. 1989 Mar 15;142(6):2081–2088. [PubMed] [Google Scholar]
  5. Böhme J., Schuhbaur B., Kanagawa O., Benoist C., Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science. 1990 Jul 20;249(4966):293–295. doi: 10.1126/science.2115690. [DOI] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Cohen P. L., Ziff M. Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol. 1977 Oct;119(4):1534–1537. [PubMed] [Google Scholar]
  8. Eisenberg R. A., Izui S., McConahey P. J., Hang L., Peters C. J., Theofilopoulos A. N., Dixon F. J. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J Immunol. 1980 Sep;125(3):1032–1036. [PubMed] [Google Scholar]
  9. Garnier J. L., Merino R., Kimoto M., Izui S. Resistance to tolerance induction to human gammaglobulin (HGG) in autoimmune BXSB/MpJ mice: functional analysis of antigen-presenting cells and HGG-specific T helper cells. Clin Exp Immunol. 1988 Aug;73(2):283–288. [PMC free article] [PubMed] [Google Scholar]
  10. Gilfillan S., Aiso S., Michie S. A., McDevitt H. O. Immune deficiency due to high copy numbers of an Ak beta transgene. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7319–7323. doi: 10.1073/pnas.87.18.7319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hudgins C. C., Steinberg R. T., Klinman D. M., Reeves M. J., Steinberg A. D. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol. 1985 Jun;134(6):3849–3854. [PubMed] [Google Scholar]
  12. Hunt D. F., Michel H., Dickinson T. A., Shabanowitz J., Cox A. L., Sakaguchi K., Appella E., Grey H. M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 1992 Jun 26;256(5065):1817–1820. doi: 10.1126/science.1319610. [DOI] [PubMed] [Google Scholar]
  13. Hyldig-Nielsen J. J., Schenning L., Hammerling U., Widmark E., Heldin E., Lind P., Servenius B., Lund T., Flavell R., Lee J. S. The complete nucleotide sequence of the I-E alpha d immune response gene. Nucleic Acids Res. 1983 Aug 11;11(15):5055–5071. doi: 10.1093/nar/11.15.5055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Izui S., Higaki M., Morrow D., Merino R. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur J Immunol. 1988 Jun;18(6):911–915. doi: 10.1002/eji.1830180612. [DOI] [PubMed] [Google Scholar]
  15. Izui S., McConahey P. J., Theofilopoulos A. N., Dixon F. J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med. 1979 May 1;149(5):1099–1116. doi: 10.1084/jem.149.5.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Janeway C. A., Jr, Conrad P. J., Lerner E. A., Babich J., Wettstein P., Murphy D. B. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol. 1984 Feb;132(2):662–667. [PubMed] [Google Scholar]
  17. Lerner E. A., Matis L. A., Janeway C. A., Jr, Jones P. P., Schwartz R. H., Murphy D. B. Monoclonal antibody against an Ir gene product? J Exp Med. 1980 Oct 1;152(4):1085–1101. doi: 10.1084/jem.152.4.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J. K., Edwards A. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature. 1990 Jun 21;345(6277):727–729. doi: 10.1038/345727a0. [DOI] [PubMed] [Google Scholar]
  19. Mathis D. J., Benoist C., Williams V. E., 2nd, Kanter M., McDevitt H. O. Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. Proc Natl Acad Sci U S A. 1983 Jan;80(1):273–277. doi: 10.1073/pnas.80.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Merino R., Fossati L., Lacour M., Izui S. Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa- bone marrow chimeric mice. J Exp Med. 1991 Nov 1;174(5):1023–1029. doi: 10.1084/jem.174.5.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Merino R., Fossati L., Lacour M., Lemoine R., Higaki M., Izui S. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur J Immunol. 1992 Feb;22(2):295–299. doi: 10.1002/eji.1830220202. [DOI] [PubMed] [Google Scholar]
  22. Merino R., Shibata T., De Kossodo S., Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol. 1989 Nov;19(11):2131–2137. doi: 10.1002/eji.1830191124. [DOI] [PubMed] [Google Scholar]
  23. Miyazaki T., Uno M., Uehira M., Kikutani H., Kishimoto T., Kimoto M., Nishimoto H., Miyazaki J., Yamamura K. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature. 1990 Jun 21;345(6277):722–724. doi: 10.1038/345722a0. [DOI] [PubMed] [Google Scholar]
  24. Nishikawa S., Sasaki Y., Kina T., Amagai T., Katsura Y. A monoclonal antibody against Igh6-4 determinant. Immunogenetics. 1986;23(2):137–139. doi: 10.1007/BF00377976. [DOI] [PubMed] [Google Scholar]
  25. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. 1987 Jul 30-Aug 5Nature. 328(6129):432–434. doi: 10.1038/328432a0. [DOI] [PubMed] [Google Scholar]
  26. Oliveira D. B., Mitchison N. A. Immune suppression genes. Clin Exp Immunol. 1989 Feb;75(2):167–177. [PMC free article] [PubMed] [Google Scholar]
  27. Rudensky AYu, Preston-Hurlburt P., Hong S. C., Barlow A., Janeway C. A., Jr Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991 Oct 17;353(6345):622–627. doi: 10.1038/353622a0. [DOI] [PubMed] [Google Scholar]
  28. Rudensky AYu, Rath S., Preston-Hurlburt P., Murphy D. B., Janeway C. A., Jr On the complexity of self. Nature. 1991 Oct 17;353(6345):660–662. doi: 10.1038/353660a0. [DOI] [PubMed] [Google Scholar]
  29. Schüppel R., Wilke J., Weiler E. Monoclonal anti-allotype antibody towards BALB/c IgM. Analysis of specificity and site of a V-C crossover in recombinant strain BALB-Igh-Va/Igh-Cb. Eur J Immunol. 1987 May;17(5):739–741. doi: 10.1002/eji.1830170527. [DOI] [PubMed] [Google Scholar]
  30. Slattery R. M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T. E., Miller J. F. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 1990 Jun 21;345(6277):724–726. doi: 10.1038/345724a0. [DOI] [PubMed] [Google Scholar]
  31. Springer T., Galfré G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979 Apr;9(4):301–306. doi: 10.1002/eji.1830090410. [DOI] [PubMed] [Google Scholar]
  32. Uehira M., Uno M., Kürner T., Kikutani H., Mori K., Inomoto T., Uede T., Miyazaki J., Nishimoto H., Kishimoto T. Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Int Immunol. 1989;1(2):209–213. doi: 10.1093/intimm/1.2.209. [DOI] [PubMed] [Google Scholar]
  33. Wofsy D., Kerger C. E., Seaman W. E. Monocytosis in the BXSB model for systemic lupus erythematosus. J Exp Med. 1984 Feb 1;159(2):629–634. doi: 10.1084/jem.159.2.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yoshiki T., Mellors R. C., Strand M., August J. T. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med. 1974 Oct 1;140(4):1011–1027. doi: 10.1084/jem.140.4.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES